AckermanKE, SlusarzK, GuerecaG, PierceL, SlatteryM, MendesN, HerzogDB, MisraM: Higher ghrelin and lower leptin secretion are associated with lower LH secretion in young amenorrheic athletes compared with eumenorrheic athletes and controls. Am J Physiol Endocrinol Metab, 302:E800–E806, 2012.
2.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Washington, DC: American Psychiatric Association; 1994
3.
GoldenNH, CarlsonJL: The pathophysiology of amenorrhea in the adolescent. Ann N Y Acad Sci, 1135:163–178, 2008.
4.
GrahamJ, BanaschewskiT, BuitelaarJ, CoghillD, DanckaertsM, DittmannRW, DöpfnerM, HamiltonR, HollisC, HoltmannM, Hulpke-WetteM, LecendreuxM, RosenthalE, RothenbergerA, SantoshP, SergeantJ, SimonoffE, Sonuga-BarkeE, WongIC, ZuddasA, SteinhausenHC, TaylorE: European Guidelines Group. European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry, 20:17–37, 2011.
5.
HanwellaR, SenanayakeM, de SilvaV.: Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivitydisorder in children and adolescents: A meta-analysis. BMC Psychiatry, 11:176, 2011.
6.
McDonaghMS, PetersonK, ThakurtaS, LowA: Drug Class Review: Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder: Final Update 4 Report. SourcePortland (OR): Oregon Health & Science University, 2011. Available at http://www.ncbi.nlm.nih.gov/books/NBK84419/pdf/TOC.pdf Accessed May15, 2015.
7.
MeczekalskiB, Podfigurna-StopaA, Warenik-SzymankiewiczA, GenazzaniAR: Functional hypothalamic amenorrhea: Current view on neuroendocrine aberrations. Gynecol Endocrinol, 24:4–11, 2008.
8.
NicolettiI, AmbrosiF, GiammartinoC, FedeliL, MannarelliC, FilipponiP: Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea. Horm Metab Res, 18:479–484, 1986.
9.
PapaleoE, DoldiN, De SantisL, MarelliG, MarsiglioE, RofenaS, FerrariA: Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome. Hum Reprod, 16:2263–2266, 2001.
10.
RopertJF, QuigleyME, YenSS: The dopaminergic inhibition of LH secretion during the menstrual cycle. Life Sci, 34:2067–2073, 1984.
11.
SahinS, YuceM, AlacamH, KarabekirogluK, SayGN, SalısO: Effect of methylphenidate treatment on appetite and levels of leptin, ghrelin, adiponectin, and brain-derived neurotrophic factor in children and adolescents with attention deficit and hyperactivity disorder. Int J Psychiatry Clin Pract, 18:280–287, 2014.
12.
YoussefMA, vanWelyM, HassanMA, Al-InanyHG, MochtarM, KhattabS, van der VeenF: Can dopamine agonists reduce the incidence and severity of OHSS in IVF/ICSI treatment cycles? A systematic review and meta-analysis. Hum Reprod Update, 16:459–466, 2010.
